Helen Torley, PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. (HALO), sold 1,923 shares at $79.28 ($153K) on 2026-07-08, disclosed to the SEC on 2026-07-09.
Scheduled sale ($153k) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.28 | 888 | $70K | 45.9% |
| 2 | $80.19 | 1,035 | $83K | 54.1% |
| Total | $79.77 avg | 1,923 | $153K | 100% |
| Filing → |
| HALO | SELL | 2026-06-03 | $3.4M | — | Filing → |
| HALO | SELL | 2026-05-13 | $3.4M | — | Filing → |
| HALO | SELL | 2026-04-07 | $635K | — | Filing → |